Skip to main content

Quanex Building Products CORP

For the period ended Jul 31, 2025. Filed Sep 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jul 31, 2025 · Filed Sep 5, 2025

NX$21.17-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statement of Stockholders’ Equity –

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Nine Months Ended July 31, 2025 · CommonStock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensive Loss · TreasuryStock · TotalStockholders’Equity
(In thousands, no per share amounts shown except in verbiage)
Balance at October 31, 2024$513$701,008$430,405$(46,428)$(74,752)$1,010,746
Net loss——(14,885)——(14,885)
Foreign currency translation adjustment———(15,951)—(15,951)
Common dividends ($0.08 per share)——(3,812)——(3,812)
Purchase of treasury stock————(3,698)(3,698)
Stock-based compensation activity:
Expense related to stock-based compensation—902——902
Stock options exercised—41——173214
Restricted stock awards granted—(1,894)——1,894—
Performance restricted stock units vested—(1,300)——1,300—
Other(1)(1,399)———(1,400)
Balance at January 31, 2025$512$697,358$411,708$(62,379)$(75,083)$972,116
Net income——20,515——20,515
Foreign currency translation adjustment———35,345—35,345
Common dividends ($0.08 per share)——(3,740)——(3,740)
Purchase of treasury stock————(23,496)(23,496)
Stock-based compensation activity:
Expense related to stock-based compensation—923———923
Restricted stock awards granted—(43)——43—
Balance at April 30, 2025$512$698,238$428,483$(27,034)$(98,536)$1,001,663
Net income——(276,007)——(276,007)
Foreign currency translation adjustment———(3,467)—(3,467)
Common dividends ($0.08 per share)——(3,681)——(3,681)
Purchase of treasury stock————(2,054)(2,054)
Stock-based compensation activity:
Expense related to stock-based compensation—937———937
Restricted stock awards granted—(69)——69—
Balance at July 31, 2025$512$699,106$148,795$(30,501)$(100,521)$717,391
Nine Months Ended July 31, 2024 · CommonStock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensive Loss · TreasuryStock · TotalStockholders’Equity
(In thousands, no per share amounts shown except in verbiage)
Balance at October 31, 2023$372$251,576$409,318$(38,141)$(77,571)$545,554
Net income——6,249——6,249
Foreign currency translation adjustment———6,081—6,081
Common dividends ($0.08 per share)——(2,645)——(2,645)
Stock-based compensation activity:
Expense related to stock-based compensation—583——583
Stock options exercised—22——378400
Restricted stock awards granted—(1,357)——1,357—
Performance restricted stock units vested—(917)——917—
Other(1)(1,192)———(1,193)
Balance at January 31, 2024$371$248,715$412,922$(32,060)$(74,919)$555,029
Net income——15,377——15,377
Foreign currency translation adjustment———(2,571)—(2,571)
Common dividends ($0.08 per share)——(2,649)——(2,649)
Stock-based compensation activity:
Expense related to stock-based compensation782———782
Stock options exercised—5——149154
Balance at April 30, 2024$371$249,502$425,650$(34,631)$(74,770)$566,122
Net income——25,350——25,350
Foreign currency translation adjustment———4,500—4,500
Common dividends ($0.08 per share)——(2,649)——(2,649)
Stock-based compensation activity:
Expense related to stock-based compensation—794———794
Stock options exercised—1——1819
Balance at July 31, 2024$371$250,297$448,351$(30,131)$(74,752)$594,136
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.